Showing 2778 results
-
Press release /ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after…
-
Press release /Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular diseasePacibekitug is a…
-
Story / -
Event /
-
Event /At this year’s European Society of Cardiology (ESC) Congress, we will be sharing the latest data and research from our cardiology portfolio, driven by our mission to ensure that no heart is lost too…